Aptamer Details

Back to Search Results

upanap-12 (ID# 7837)

* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
Urokinase-type plasminogen activator
N/A nM (reported value)
HBS, 2 mM MgCl2, 0.1% BSA, and 0.025% Tween20
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Human urokinase-type plasminogen activator
Authors provided IC50,values for inhibition of interaction between human uPA and uPAR with upanap-12 having the lowest value.

Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.

Daniel Miotto Dupont, Jeppe Buur Madsen, Roland Karl Hartmann, et al. Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding. RNA 2010 16: 2360-2369

Have your aptamer oligo synthesized ORDER